Injectable
Thiotepa
5 mg/mL · Powder for IV injection · Graft-rejection prevention in HSCT
Product data
- Strength
- 5 mg/mL
- Dosage form
- Powder for IV injection
- Dosage-form group
- Injectable
- Therapeutic area
- Graft-rejection prevention in HSCT
- Status
- Ready for technology transfer
- Portfolio
- Injectable
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23